A Study Regarding Tissue Response During and After Treatment for Anal Cancer

Recruiting now

Conditions studied: Anal Cancer

In brief

The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.

Key facts

Study ID

NCT05939401

Run by

Sahlgrenska University Hospital

People needed

400

Starts

2023-12-01

Expected to finish

2029-12-01

Last updated by the study team

2025-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed or recurrent anal cancer

You may not qualify if…

• No diagnosis of anal cancer, contraindication to biopsies and blood samples

Where it is running

• Dept. of Surgery, Sahlgrenska University Hospital/Ostra — Gothenburg, Sweden (enrolling)
• Sahlgrenska University Hospital — Gothenburg, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.